Abstract
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) study group (1) reported that, based on a post hoc analysis, visit-to-visit variability of fasting blood glucose (FBG) is positively associated with all-cause mortality but not with cardiovascular events in subjects without diabetes, while the association is not statistically significant in those with diabetes. Glycemic variability was assessed from FBG values at baseline, 24 months, and 48 months in persons without cardiovascular disease prior to a follow-up period of up to several years. Metrics of glycemic variability …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
